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Background: Almost all of the evidence on the benefits of smoke-free legislation on child health comes from
evaluations in high-income countries. We investigated the effects of Thailand’s 2010 comprehensive smoke-
free legislation on neonatal and infant mortality.
Methods: To overcome some of the methodological issues inherent to traditional quasi-experimental meth-
ods, we applied the novel synthetic control approach. Using 20012017 country-level panel data from the
World Bank and Penn World datasets, we estimated the effects of smoke-free legislation as the difference
between the outcome trends in Thailand versus those in a synthetic control country. The synthetic control
country was composed of ‘control’ middle-income countries without comprehensive smoke-free legislation
to recreate trends in Thailand in the 20012009 pre-legislation outcomes and covariates. We compared the
legislation effects to ‘placebo effects’ obtained for each control country by fictitiously assuming that compre-
hensive smoke-free legislation was introduced there in 2010, similar to Thailand.
Findings: Neonatal and infant mortality decreased by 2.9% and 2.8%/year respectively following smoke-free legis-
lation, with an estimated 7463 infant deaths (including 4623 neonatal deaths) having been averted over eight
years. The results were robust to different specifications of the control countries. Comparison with placebo effects
indicated that the findings were unlikely to be attributable to factors other than the smoke-free legislation.
Interpretation: Expanding comprehensive smoke-free policies to middle-income countries can support
national efforts to achieve Sustainable Development Goal 3.2 for reducing preventable early-life deaths.
Funding: Netherlands Lung Foundation, HDRUK, Asthma UK center for Applied Research and NIHR Global
Respiratory Health Unit (RESPIRE).
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Tobacco smoke exposure during perinatal and early life increases
the risk of stillbirth, preterm birth, low weight birth, and neonatal and
infant death [13]. Annually, approximately 166,000 avoidable deaths
and 6¢6 million disability-adjusted life years (DALYs) among childrencan be attributed to second-hand smoke exposure worldwide [4,5]. As
a consequence, the protection of children from the harm of tobacco
smoke exposure has been identified as a vital tool to achieve the
United Nations’ Sustainable Development Goals 3.2.1 and 3.2.2, aimed
at improving under-five and neonatal mortality rates [6].
Smoke-free policies have the potential to reduce tobacco smoke
exposure during pregnancy and infancy, and through so doing reduce
the risk of a number of serious adverse health outcomes [7]. Based on
a recent systematic review and meta-analysis, implementation of
smoke-free legislation covering enclosed public places was associated
with a 3¢8% (95% confidence interval [CI] 1¢2 to 6¢4) decrease in pre-
term birth rates, a 9¢8% (95% CI 3¢0 to 16¢6) decrease in rates of hospital
Research in context
Evidence before this study
Tobacco use is the leading preventable cause of mortality and
morbidity globally, and children are especially vulnerable.
There is a growing body of literature supporting positive effects
of smoke-free legislation on child health; according to our 2017
systematic review smoke-free legislation was associated with
substantial reductions in preterm birth (by 3.8% [95% CI 1.2 to
6.¢4]), hospital attendance for asthma (by 9¢.8% [95% CI 3.0 to
16.¢6]), and hospital attendance for lower respiratory tract
infections (by 18¢.5% [95% CI 4.2 to 32.¢8]). In England smoke-
free legislation was furthermore associated with a significant
reductions in neonatal mortality by 7¢6% (95% CI 3¢4 to 11¢7)
and infant mortality by 6¢3% (95% CI 2¢9 to 9¢6). However, the
generalizability of these findings to low- and middle-income
countries is unclear since in such countries, high background
outdoor and indoor air pollution, low awareness of tobacco-
related harm, and poor economic conditions might suppress
the positive effects of smoke-free legislation. In a recent study,
implementation of comprehensive smoke-free laws in Brazil
was associated with an immediate 5¢2% (95% CI 2¢1 to 8¢3) and
an additional annual 0¢4% (95% CI 0¢1 to 0¢7) decrease in infant
mortality and an immediate 3¢4% (95% CI 0¢1 to 6¢7) decrease in
neonatal mortality.
Added value of this study
We found that the child health benefits of smoke-free legisla-
tion in Thailand were comparable to those found in high-
income countries. Our study confirms the effectiveness of
smoke-free legislation to promote neonatal and infant survival
in a middle-income setting where previously only very limited
research was conducted. To our knowledge, this is the first
assessment of the impact of tobacco control legislation on child
health using the robust synthetic control method which pro-
vided further robust evidence that the confirmed link between
smoke-free legislation and child health is indeed causal.
Implications of all the available evidence
Taken together, the available evidence indicates that smoke-
free legislation can indeed also bring about substantial child
health benefits in middle-income countries. Tobacco control
measures are particularly important in less developed regions
where the tobacco industry retains a very influential role. The
findings from this study support the need for further accelera-
tion of the implementation of smoke-free policies across the
globe.
2 M.K. Rado et al. / EClinicalMedicine 27 (2020) 100560attendance for asthma exacerbations, and an 18¢5% (95% CI 4¢2 to 32¢8)
decrease in rates of hospital attendance for lower respiratory tract
infections [7]. Furthermore, evidence from England indicated that
smoke-free legislation reduced neonatal mortality by 7¢6% (95% CI 3¢4
to 11¢7) and infant mortality by 6¢3% (95% CI 2¢9 to 9¢6) [8].
At present, the evidence on the early-life health impact of smoke-
free legislation is almost entirely derived from evaluations in high-
income countries (HICs) [7,9]. These findings may not easily be gener-
alized to low- and middle-income countries (LMICs) for a number of
reasons  for example, outdoor air pollution, indoor air pollution due
to biomass used for cooking and heating, household tobacco smoke
exposure, and tobacco smoke exposure among pregnant women are
significantly higher, whereas awareness of tobacco-related harms is
significantly lower in LMICs than in HICs [1012] Moreover,pregnancy outcomes are generally poorer in LMICs than in HICs due
to reduced antenatal care capacities [13]. We are aware of only one
study that investigated the effectiveness of smoke-free legislation on
infant health from a middle-income country (MIC), namely Brazil [9].
Based on this study, the implementation of smoke-free laws across
Brazil was estimated to have prevented 15,068 infant deaths over
12 years [9].
Our study extends the scope of research to Thailand, a MIC from the
East Asian and Pacific region. Thailand has been a tobacco control
leader in the region for a long time [14,15]. Partial smoke-free legisla-
tion came into practice in Thailand in 1992, prohibiting smoking in
public places where such legislation can easily be implemented such
as hospitals, schools, and air-conditioned workplaces (Fig. S1) [16,17].
However, it still allowed smoking in non-air-conditioned public areas
and workplaces. In 2010, the legislation was extended to become com-
prehensive as advocated by the World Health Organization (WHO),
prohibiting smoking in all indoor public places, indoor workplaces,
public transport (except international airports where designated
smoking areas are available), and some outdoor areas [5,18,19]. Previ-
ous studies found that the comprehensive smoke-free legislation was
enforced well (especially in case of indoor workplaces, indoor public
places, and restaurants) [20,21]. Compliance was rated in 2013 to be 7/
10 based on a WHO evaluation [22]. Further, the implementation of
smoke-free legislation was followed by a gradual decrease in smoking
prevalence (i.e. from 21¢7% in 2010 to 19¢9% in 2016) [23] and in sec-
ond-hand smoke exposure at home or enclosed public places among
youth (i.e. from 68% in 2009 to 39% in 2015) [24].
We applied a novel synthetic control method to estimate the
effects of Thailand’s introduction of comprehensive smoke-free legis-
lation on neonatal and infant mortality. This method recreates the
counterfactual scenario (i.e. what would have happened if smoke-
free legislation had not been implemented) as a weighted average of
multiple control countries that did not introduce comprehensive
smoke-free legislation during the study period [25,26]. The advan-
tage of this method, when compared to other quasi-experimental
methods, is that it provides a better counterfactual scenario (i.e. it
recreates better the pre-legislation trends in Thailand), allowing less
biased estimation [2527].
2. Methods
2.1. Study design and setting
Our study covered the pre-legislation period between 2001 and
2009 and the post-legislation period 2010 to 2017. Data from before
2001 were not included to ensure that any impact of the 2001 ''30
Baht'' Thai healthcare reform on underlying trends in neonatal or
infant mortality would not distort our estimation [28]. First, we esti-
mated how neonatal and infant mortality statistics would have pro-
gressed in Thailand if the smoke-free legislation had not been
implemented. The synthetic control method estimates this counter-
factual scenario by constructing a synthetic control country as a com-
bination of available control countries. In our case, the synthetic
control country was the weighted average of other MICs with avail-
able data that did not implement comprehensive smoke-free legisla-
tion until the end of the observation period (2017), but had been
otherwise similar to Thailand pre-legislation (Table S1). Thereafter,
we estimated the impact of the smoke-free legislation as the differ-
ence between temporal patterns in the outcomes between Thailand
and its synthetic control country post-legislation.
2.2. Variables and data sources
The set of available control countries used for constructing the syn-
thetic control country is referred to as the donor pool. We selected
countries for the donor pool that did not implement comprehensive
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according to the WHO Report on the Global Tobacco Epidemic 2019
[5]. WHO defines national smoke-free legislation as comprehensive if
it prohibits smoking in indoor workplaces and indoor public places,
including health-care facilities, educational facilities, government facil-
ities, public transports, bars, and restaurants, without allowing desig-
nated smoking rooms [29]. The donor pool should resemble the main
characteristics of Thailand in order to avoid interpolation and extrapo-
lation bias (i.e. bias arising when there is not sufficient overlap
between the control and intervention groups in their outcomes)
[30,31]. Thus, we restricted the donor pool to MICs according to the
World Bank’s Country Classification System [32]. After omission of 12
countries with missing values in the predictor or outcome variables
(Table S2), 49 countries constituted the final donor pool.
Table 1 provides an overview of the outcome and predictor varia-
bles, all of which were obtained annually. Data on the outcome varia-
bles  national-level neonatal mortality and infant mortality  were
extracted from the World Bank Database for the 20012017 observa-
tional period [33]. We selected predictor variables based on their
impact on the outcomes, as shown in previous work [30,34]. Conse-
quently, we controlled for variables that capture the social and eco-
nomic status of the countries, quality and access to healthcare
facilities, and air pollution. Additionally, we also used as predictors
the pre-legislation values of the outcome variables. Predictors were
collected from the World Bank Database, except for ‘Openness to
trade’which was obtained from the PennWorld Dataset [35].
2.3. Constructing the synthetic control countries
We constructed two synthetic control countries: one reproducing the
pre-legislation trend in neonatal mortality, the other mirroring the trend
in infant mortality. Each synthetic control country was constructed as a
weighted average of countries from the donor pool, as follows.
Let N be the number of countries, n ¼ 1is Thailand and n 2 are
the countries in the donor pool, Ytn denotes the outcome properties
(i.e. neonatal or infant mortality) of the n country in t year, and
WYn refers to the weight of n country in constructing the synthetic
control country [25,26,30]. The Ytsynth outcome variables at t year in a
synthetic control country can be calculated as the weighted average




WYn  Ytn ð1Þ
The WYn country weights were the result of the optimization that
ensures that Thailand and the synthetic control country were as simi-
lar as possible in a set of Xtn pre-legislation predictors [25,26,30]. This
algorithm took into account that not all predictors contributed
equally to a given outcome variable (e.g. the lagged value of infant
mortality better predicted current infant mortality than the propor-
tion of the population living in a rural area did, Table S3). We applied
the default optimization method that minimalized the root mean
squared prediction error (RMPSE) for the pre-legislation period (Eq.
(S1)) using Broyden, Fletcher, Goldfarb, and Shanno’s (BFGS) and
quasi-Newton algorithms [36]. We built the synthetic control coun-
tries using the Synth package, which runs in the R environment [36].
2.4. Estimating the legislation effect
After constructing the synthetic control countries based on the
pre-intervention trends, we assessed the aYt dynamic legislation
effect in t year quantified as the post-legislation difference in Y out-
come variable of Thailand and that of the synthetic control country:
aYt ¼ Yt1Ytsynth; ð3Þ
where Ytsynth is defined in Eq. (1).To obtain the percentage change in the outcome associated with the
legislation for each post-legislation year, we divided the aYt legislation
effect by the outcome of the synthetic control country in t year. Further,
we calculated the year-specific numbers of avoided deaths as the prod-
uct of aYt legislation effect in t year and the year-specific number of live
births (i.e. crude birth rate per 1000 multiplied by the total number of
population as derived from the Word Bank Database). The sum of the
year-specific avoided deaths quantifies the total legislation effect.
2.5. Placebo test
We conducted ‘placebo tests’ that compared the legislation effect to
the ‘placebo effects’ that were obtained for each control country by ficti-
tiously assuming that comprehensive smoke-free legislation was intro-
duced there at the same time as in Thailand (i.e. 2010). This test allowed
us to assess whether the estimated aYt legislation effect was indeed
most likely a response to the legislation or whether it could be merely
the result of other (i.e. confounding or co-intervention) processes.
The placebo effects were estimated in three steps [26]. First, we
constructed a synthetic ‘control country’ for every control country
from the donor pool using the same predictors and pre-legislation
period as for constructing a synthetic control country for Thailand.
Second, we excluded from further consideration those countries for
which we could not find a synthetic control country that reproduced
well the outcomes in the pre-legislation period (20012009). Two
exclusion criteria were used in separate analyses: we discarded coun-
tries with pre-legislation RMPSE higher than 0¢03 or higher than in
Thailand (i.e. 0¢14 for neonatal mortality and 0¢19 for infant mortal-
ity). Third, for each remaining k country, we defined the vYtk placebo
effect as the difference between the Yk outcome of the k control coun-
try and Ytsynthk of its synthetic ‘control country’.
vYtk ¼ YtkYtsynthk ¼ Ytk
XN
n¼1;n6¼k
WYnk  Ytn; where k 6¼ 1 ð4Þ
2.6. Sensitivity analyses
We explored the robustness of our analyses by undertaking four
sets of sensitivity analyses using different donor pools. First, we
tested the effect of being more restrictive with economic proximity
and narrowed down the donor pool to only upper-MICs (according to
the World Bank’s Country Classification System) [32]. In this case, we
restricted the analysis to 28 eligible control countries (five countries
were not included due to missing data, Table S2). Second, we defined
the donor pool based on geographical proximity to Thailand instead
of using economic proximity. More specifically, we selected 12 coun-
tries from the East Asian and Pacific region (12 countries from this
region were not included due to missing data, Table S2). Third, we
removed from the donor pool the control country that received the
highest weight in creating the synthetic control country in the main
analysis to test whether the results of the main analysis could be
merely attributed to processes (e.g. health care reforms, the introduc-
tion of new vaccines, epidemics) in this important control unit [37].
Fourth, we reduced the donor pool to countries that did not have any
smoke-free legislation (not even partial) during the study period.
Further, we assessed sensitivity of our results to excluding donor
countries base on missing data. We used the imputeTS package (using
interpolation function) to impute missing values [38], retaining 53
countries and omitting 9 countries where interpolation was not possi-
ble due to less than three observations in predictors or due to missing
values in the outcome variable. Finally, we conducted a sensitivity anal-
ysis controlling for annual cigarette consumption at the country-level.
As comparative and historical smoking prevalence data were not avail-
able, we used estimated cigarette consumption data from tobacco sales
data (36 countries were omitted due to missing data) [39].
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This study did not require ethical approval since only aggregated
and publicly available data were used.
2.8. Role of the funding source
The funders of the study had no role in study design, data collec-
tion, data analysis, data interpretation, or writing of the report. The
corresponding author had full access to all the data in the study and
had final responsibility for the decision to submit for publication.
3. Results
Table 2 displays the selected control countries and their respec-
tive weights contributing to the synthetic control countries. For
reproducing the pre-legislation neonatal mortality trend in Thailand,
the synthetic control country was the weighted average of Malaysia,
Nicaragua, Moldova, China, and Bhutan (listed according to their
weights). The infant mortality trend in Thailand was replicated as a
weighted combination of Malaysia, Nicaragua, Moldova, Sri Lanka,
China, Bangladesh, and Morocco. The weighted average of the control
countries adequately reproduced the pre-legislation average values
of the predictor variables (Table 3) and the temporal trends in the
outcomes of Thailand (Fig. 1).
Fig. 1 shows that there was a gradual divergence of the neonatal/
infant mortality trends over time between Thailand and the control
country in the 20102017 post-legislation period. Over this period,
the relative reduction in neonatal mortality added up to 20¢4% (on
average 2¢9% per annum) and that in infant mortality to 19¢3% (on
average 2¢8% per annum). In absolute terms, this translates into an
estimated aversion of 7463 infant deaths, including 4623 neonatal
deaths, over eight years.
To assess whether our findings could have been influenced by
other factors than the comprehensive smoke-free legislation, we esti-
mated a placebo effect for each control country (Fig. 2AD, Tables S4
and S5). The vast majority of control countries had a placebo effect
that was smaller than the estimated legislation effect for Thailand.
When we restricted the donor pool to those countries for which a
very well-fitting synthetic control could be constructed (i.e. RMPSE
was lower than the level that Thailand had; Fig. 2B and D), only three
out of 18 countries had a larger placebo effect than the estimated leg-
islation effect for Thailand in case of neonatal mortality and five out
of 15 in case of infant mortality. To explore the potential underlying
reasons for why some of the placebo effects were larger than the esti-
mated treatment effect in Thailand, we performed a number of pre-
specified sensitivity analyses.
We restricted the donor pool to (1) upper-MICs (Fig. 3AD and
Table S6), and (2) countries from the East Asian and Pacific region
(Fig. 4AD and Table S7), (3) the donor pool without the country
with the highest weight in the main analysis, Malaysia (Table S8 and
Fig. S2), and (4) countries without partial smoke-free legislation
(Table S9 and Fig. S3). All of these scenarios generated substantive
legislation effects in Thailand, similar to the main analysis. Further-
more, when the donor pool was restricted to countries economically
or geographically more similar to Thailand than in the main analysis,
the legislation effects in Thailand were almost invariably larger than
the placebo effects obtained from control countries (see Figs. 3 and
4). When we consider only those control countries for which a very
well-fitting (i.e. RMPSE lower than the level that Thailand had) syn-
thetic control was available (Fig. 3B, D and Fig. 4B, D), only Belize had
a placebo effect that was slightly larger than the estimated treatment
effect in Thailand, and only for infant mortality. Further, results were
robust in sensitivity analyses in which we imputed missing values
(Table S10 and Fig. S4) and accounted for cigarette consumption
(Table S11 and Fig. S5).4. Discussion
Using the novel synthetic control method for the first time in rela-
tion to the impact of smoke-free legislation on child health, we found
that the 2010 national implementation of comprehensive smoke-free
legislation in Thailand was associated with substantive decreases in
neonatal and infant mortality (on average 2¢9% and 2¢8% per
annum, respectively), translating to 7463 averted infant deaths
(including 4623 averted neonatal deaths) over eight years. Placebo
tests among countries similar to Thailand indicate that these changes
were unlikely to be due to other factors. This indicates that smoke-
free legislation is also likely to bring about positive changes in infant
health in MICs, where there is currently a limited body of evidence to
guide decision making [7,9].
The main strength of this study was the use of a synthetic control
method that produces less biased estimations than other commonly
used quasi-experimental methods [25,26,40,41]. The major challenge
of estimating an intervention effect on observational data is the selec-
tion of appropriate control units. Most of the previously employed
methods failed to adequately address this issue since they did not
use any actual control units (e.g. used single-arm interrupted time
series analysis) or used control units that deviated from the treat-
ment unit prior to the introduction of the new legislation. Some pre-
vious studies attempted to adjust for pre-legislation differences
between the control and intervention units using traditional regres-
sion methods (e.g. fixed-effect model), however, these methods are
often subject to extrapolation or interpolation bias [25,26,42]. The
synthetic control method provides a data-driven, transparent solu-
tion to the selection of appropriate control units. Further, the syn-
thetic control method relaxes the linearity assumption of traditional
longitudinal methods by allowing the difference in outcome between
the treated and control countries to dynamically vary over time
[25,26].
The synthetic control method offers the opportunity to assess
whether the estimated effects may be attributed to processes other
than the smoke-free legislation. We compared the effect of legislation
in Thailand to the placebo effects that were obtained for each country
of the donor pool by fictitiously assuming that a smoke-free law had
been introduced in those countries. In the main analyses, a few pla-
cebo effects were stronger than the estimated effect in Thailand (in
case of neonatal mortality: the Dominican Republic, Ghana, and
Morocco; in case of infant mortality: Armenia, Bangladesh, Belize,
Cameroon, and Ghana). These countries might display a larger pla-
cebo decrease than the actual decrease in Thailand due to various
reasons. Armenia, for example, almost tripled its health expenditure
in the post-legislation period [33]. The other exceptional cases typi-
cally occurred in lower-MICs, as opposed to upper middle-income
Thailand, which might explain the more rapid improvements in
infant mortality measures. After reducing the donor pool to countries
that were economically or geographically closer to Thailand, we
found that the legislation effect in Thailand always exceeded the pla-
cebo effects in the respective donor pools, except in case of infant
mortality in Belize. However, Belize implemented (at the same time
as the Thai smoke-free legislation, 2010) a successful hospital reform
aiming to improve maternal and neonatal care which could explain
their exceptional developments [43,44]. These results indicate that
the observed improvements in neonatal and infant mortality in Thai-
land after 2010 as compared to the synthetic control country are
unlikely to be related to factors other than the national introduction
of comprehensive smoke-free legislation.
Our estimations were robust across different specifications of the
donor pool. All sensitivity analyses showed a substantive reduction
of neonatal and infant mortality in Thailand following comprehensive
smoke-free legislation. Although these sensitivity analyses were use-
ful in testing the sensitivity of our results to different model specifica-
tions, they permitted a less robust estimation than the main analysis
Table 1
Description of the outcome and predictor variables.
Variables Database Definition
Outcome variable Neonatal mortality World Bank Database (20012017 period) The number of neonates who die within 28 days
after birth per 1000 livebirths
Infant mortality World Bank Database (20012017 period) The number of deaths among infants younger
than one year of age per 1000 livebirths
Social and economic variables GDP World Bank Database (20012009 period) Gross domestic product per capita (PPP)
Rural population World Bank Database (20012009 period) The proportion of the population living in rural
areas as defined by national statistical offices
Female primary education
completion rate
World Bank Database (20012009 period) The ratio of the number of new female entrants in
the last grade of primary education (regardless
of age) and the number of females at the
entrance age for the last grade of primary
education
Fertility rate World Bank Database (20012009 period) The average number of children born to a woman
(given women survive the childbearing age and
fertility is in line with age-specific fertility rates
of the specified year)
Openness to trade Penn World Dataset (20012009 period) The share of exports plus imports compared to
nominal GDP
Health-care indicators Health expenditure World Bank Database (20012009 period) Current health expenditure per capita expressed
in international dollars (PPP)
Hospital beds World Bank Database (20012009 period) The number of hospital beds available per 1000
people
Drinking water World Bank Database (20012009 period) The proportion of the population with access to
basic drinking water (i.e. collection time <
30 min)
Air pollution Clean cooking World Bank Database (20012009 period) The proportion of the population with access to
clean fuels and technologies for cooking
CO2 World Bank Database (20012009 period) Carbon dioxide emissions in kiloton
Abbreviations: GDP= Gross domestic product; PPP= Purchasing power parity; CO2= Carbon dioxide.
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ticularly reduced after the inclusion of cigarette consumption as a
predictor. These data were unavailable for several important control
countries, thus less appropriate control countries constituted the syn-
thetic control country in this case. For example, Armenia was now
included which likely explains the lower effect estimate as this coun-
try had tripled its health expenditure in the post-legislation period.
Furthermore, the added value of this sensitivity analysis was low, as
the cigarette consumption variable received a very low weight in cre-
ating the synthetic control country (<0¢01%). Finally, a disadvantage
of these data is that they did not incorporate illicit trade in tobacco
sales and had low to moderate reliability for some LMICs [39].
Although we applied a novel and robust method, our study still
had to rely on a quasi-experimental design since national policy
interventions are typically not amendable to being evaluated using
randomized control trials [27,45]. This approach, in general, limits
researchers’ ability to rule out all residual confounding and potential
influence of co-interventions. We are unaware of relevant national
co-interventions in Thailand in the time period of that may haveTable 2
Country weights in the synthetic control countries for
reproducing infant mortality and neonatal mortality
trends in Thailand, 20012009.
Countrya Country weights






Sri Lanka  0¢071
Bangladesh  0¢024
Morocco  0¢001
a This table contains only those control countries that
contributed to the constitution of the synthetic control
country with a larger than 0 weight.influenced our findings. Similar to other quasi-experimental studies,
our long-term estimation might have been influenced by subsequent
laws (e.g. a law requiring that health warnings cover at least 85% of
the surface of cigarette packages introduced in 2014) [46].
In the light of the quasi-experimental nature of our study, it is
important to consider circumstantial evidence supporting likely cau-
sality of our findings. First, the fact that smoke-free legislation was
enforced well in Thailand increases the likeliness of it having an
impact on smoking behavior and health outcomes [20,21]. Based on
the WHO Tobacco Control Reports, initial compliance with the com-
prehensive smoke-free law was good (i.e. rated as 7/10 based on the
2013 WHO evaluation) [22]. Although compliance somewhat
decreased in subsequent years (i.e. rated as 5/10 based on 2019 WHO
report) [5], this was primarily due to reduced compliance with the
legislation in bars, a public place rarely frequented by pregnant
women and infants. As such, this decrease in the rating is unlikely to
affect our estimation of the law’s impact on early-life survival. Sec-
ond, based on World Bank data, smoking prevalence steadily
decreased from 21¢7% in 2010 to 19¢9% in 2016 [23], with Global
Adult Tobacco Survey (GATS) data indicating that the decrease in the
first year of the comprehensive smoke-free legislation occurred
mainly among women [47]. Third, the Global Youth Tobacco Survey
(GYTS) showed that between 2009 and 2015 second-hand smoke
exposure at home or enclosed public places dropped dramatically
among youth (i.e. from 68% to 39%) [24]. Decreased exposure to
tobacco smoke exposure in the home via norm spreading is likely to
be an important contributor to reducing overall second-hand smoke
exposure among infants and pregnant women, hence benefiting neo-
natal and infant survival [48,49].
Despite achieving an overall good pre-legislation fit between
Thailand and its synthetic countries, some deviation between them
can be traced on the year before the intervention; a similar pattern
was however also observed in a number of placebo tests. For Thai-
land, this initial divergence could occur due to an anticipation effect
that has been described previously in other jurisdictions in relation
to smoke-free legislation [50]. Further, partial smoke-free legislation
Table 3
The mean values of the predictors across the pre-legislation period (20012009).
Variables Thailand Donor pool Synthetic control country 1 (for neonatal
mortality)
Synthetic control country 2 (for infant
mortality)
N (number of countries) 1 49 5 7
Neonatal mortality (birth per 1000 livebirths) 9¢49 20¢02 9¢53 8¢84
Infant mortality (birth per 1000 livebirths) 14¢70 34¢90 16¢24 14¢75
GDP (PPP) 11392¢68 7713¢82 10303¢71 11314¢74
Health expenditure (PPP) 333¢68 323¢40 360¢87 376¢75
Clean cooking (proportion of the population) 70¢19 55¢22 70¢72 70¢50
Hospital beds (per 1000 people) 2¢15 2¢59 2¢15 2¢15
Drinking water (proportion of the
population)
95¢75 82¢75 89¢21 90¢32
CO2 (kiloton) 238077¢12 194627¢53 213658¢61 237615¢41
Rural population (proportion of the
population)
62¢53 52¢28 42¢06 43¢87
Female primary education completion rate
(proportion of the population)
86¢25 88¢25 91¢34 93¢03
Fertility rate (average number of children) 1¢58 3¢13 2¢31 2¢30
Openness to trade (exports plus imports/
nominal GDP)
143¢53 90¢85 140¢15 143¢40
Abbreviations: GDP= Gross domestic product; PPP= Purchasing power parity; CO2= Carbon dioxide.
6 M.K. Rado et al. / EClinicalMedicine 27 (2020) 100560was already in place even before the smoke-free law became com-
prehensive in 2010. However, this initial partial law was not well
enforced based on a 2008 WHO evaluation, likely limiting its effec-
tiveness [51]. Nevertheless, in the main analysis, we may have under-
estimated the true impact of a comprehensive law introduced against
no background of any smoke-free policy, as Thailand already had lim-
ited smoke-free legislation in place. The sensitivity analysis compar-
ing Thailand to countries without any smoke-free legislation (as
opposed to also including countries with partial legislation) showed
a larger impact on neonatal mortality than in the main analysis. This
is in agreement with findings from Brazil, where the neonatal sur-
vival benefits were larger for comprehensive versus partial smoke-
free laws [9]. However, these later results need to be cautiously inter-
preted due to a significantly reduced size of the donor pool. Finally,
our study design was more limited compared to other studies thatFig. 1. Trends in neonatal and infant mortality rate: Thailacould select municipality-level units as compared to our country-
level units or measure the outcomes on a monthly basis instead of
our annual measurements [9].
Our results from Thailand concur with previous studies which
were almost invariably conducted in HICs [7], although Thailand is
embedded in a less favorable social, economic, and environmental
setting. Although such aspects may have been anticipated to reduce
the effectiveness of smoke-free legislation for example due to higher
background levels of air pollution, other aspects such as compliance
with and enforcement of the law, or cultural beliefs around smoking
are also important and can be variable both across and within HIC
and LMIC settings. The previous evidence indicates that smoke-free
legislation decreases perinatal and infant tobacco smoke exposure,
and in turn, improves infant health and averts a substantive number
of infant deaths [7,52]. Our estimated legislation effects in Thailandnd versus the synthetic control country (20012017).
Fig. 2. The estimated legislation effects in Thailand and placebo effects in middle-income countries that did not introduce comprehensive smoke-free legislation.
M.K. Rado et al. / EClinicalMedicine 27 (2020) 100560 7are of similar magnitude in comparison to these earlier studies, as
well as to a recent study conducted in Brazil [9]. By applying a novel
and robust method, our findings strengthen the argument that the
link between smoke-free policies and improvements in infant health
is indeed causal and not merely due to inappropriate methodological
approaches or contextual factors.
Future research should focus on capturing the effects of smoke-
free legislation across multiple countries where such assessments
are currently lacking. Recent developments in the syntheticFig. 3. The estimated legislation effects in Thailand and placebo effects in upper-middlcontrol method may provide a robust vehicle to undertake this as
this permits the simultaneous observation of multiple ‘treated’
countries [5355] Finally, future studies should also extend the
scope of research to assess effectiveness of extending smoke-free
policies beyond enclosed public places. Thailand provides an inter-
esting case study for estimating such novel legislation since it has
recently banned smoking in beaches and in private homes where
the smoker could endanger the health of other residents such as
children [56,57].e-income countries that did not introduce comprehensive smoke-free legislation.
Fig. 4. The estimated legislation effects in Thailand and placebo effects in countries from the East Asian and Pacific region countries that did not introduce comprehensive smoke-
free legislation.
8 M.K. Rado et al. / EClinicalMedicine 27 (2020) 100560In conclusion, our findings support the need for implementing
comprehensive smoke-free policies beyond high-income settings.
Despite the less favorable conditions in MICs, smoke-free legislation
can potentially bring about similarly positive changes in infant health
as in wealthier countries. Extending smoke-free policies to other
countries is essential as still only 22% of the world’s population is pro-
tected by a comprehensive smoke-free law [5]. In MICs, strong
tobacco control policy could counterbalance the increasing influence
of the tobacco industry [5]. Further, expanding smoke-free policies
could help to reach SDG 3.2. which otherwise might not be achieved
in MICs [58]. Clean air should not be the privilege for children in
HICs, but the right of all children around the world [6].
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